{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:04:06Z","timestamp":1784171046067,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,15]]},"DOI":"10.7759\/cureus.112748","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:23:23Z","timestamp":1784168603000},"source":"Crossref","is-referenced-by-count":0,"title":["Primary Gingival Mucosal Melanoma: A Case Report and Comparison With Cutaneous Melanoma"],"prefix":"10.7759","author":[{"given":"Juan","family":"Berr\u00edos Cordero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaldo","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M","family":"Torres Col\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Mojica-Ma\u00f1osa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.10019","article-title":"Primary mucosal malignant melanoma of the head and neck","volume":"24","author":"Patel SG","year":"2002","unstructured":"Patel SG, Prasad ML, Escrig M, et al.. Primary mucosal malignant melanoma of the head and neck. Head Neck. 2002, 24:247-57. 10.1002\/hed.10019","journal-title":"Head Neck"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-023-01453-x","article-title":"Mucosal melanoma: epidemiology, clinical features, and treatment","volume":"25","author":"Sergi MC","year":"2023","unstructured":"Sergi MC, Filoni E, Triggiano G, Cazzato G, Intern\u00f2 V, Porta C, Tucci M. Mucosal melanoma: epidemiology, clinical features, and treatment. Curr Oncol Rep. 2023, 25:1247-58. 10.1007\/s11912-023-01453-x","journal-title":"Curr Oncol Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJOMS.2023.09.002","article-title":"Oral mucosal melanoma: a systematic review of case reports and case series","volume":"36","author":"Barata B","year":"2024","unstructured":"Barata B, Freitas F, Vilares M, et al.. Oral mucosal melanoma: a systematic review of case reports and case series. J Oral Maxillofac Surg Med Pathol. 2024, 36:388-95. 10.1016\/J.AJOMS.2023.09.002","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4274\/tao.2022.2022-7-5","article-title":"Mucosal melanoma in situ of the oral cavity: a case report and systematic review of the literature","volume":"60","author":"Jasper P","year":"2022","unstructured":"Jasper P, Jungbauer WN, Poupore NS, Nguyen SA, Howell J, Neville BW, Day TA. Mucosal melanoma in situ of the oral cavity: a case report and systematic review of the literature. Turk Arch Otorhinolaryngol. 2022, 60:161-9. 10.4274\/tao.2022.2022-7-5","journal-title":"Turk Arch Otorhinolaryngol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-20-0839","article-title":"Meta-analysis and systematic review of the genomics of mucosal melanoma","volume":"19","author":"Broit N","year":"2021","unstructured":"Broit N, Johansson PA, Rodgers CB, Walpole ST, Newell F, Hayward NK, Pritchard AL. Meta-analysis and systematic review of the genomics of mucosal melanoma. Mol Cancer Res. 2021, 19:991-1004. 10.1158\/1541-7786.MCR-20-0839","journal-title":"Mol Cancer Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605635","article-title":"Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT","volume":"102","author":"Handolias D","year":"2010","unstructured":"Handolias D, Hamilton AL, Salemi R, et al.. Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT. Br J Cancer. 2010, 102:1219-23. 10.1038\/sj.bjc.6605635","journal-title":"Br J Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin MB","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al.. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging. CA Cancer J Clin. 2017, 67:93-9. 10.3322\/caac.21388","journal-title":"CA Cancer J Clin"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2011.03.007","article-title":"Sentinel lymph nodes in cutaneous melanoma","volume":"31","author":"Prieto VG","year":"2011","unstructured":"Prieto VG. Sentinel lymph nodes in cutaneous melanoma. Clin Lab Med. 2011, 31:301-10. 10.1016\/j.cll.2011.03.007","journal-title":"Clin Lab Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.179982","article-title":"Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma","volume":"9","author":"Vos JL","year":"2024","unstructured":"Vos JL, Traets JJ, Qiao X, et al.. Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma. JCI Insight. 2024, 9:10.1172\/jci.insight.179982","journal-title":"JCI Insight"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1441410","article-title":"Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes","volume":"15","author":"Shan Z","year":"2024","unstructured":"Shan Z, Liu F. Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes. Front Immunol. 2024, 15:1441410. 10.3389\/fimmu.2024.1441410","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/JCRT.JCRT_1682_23","article-title":"Mucosal melanoma: a series of seven cases and review of literature","volume":"20","author":"Aashita","year":"2024","unstructured":"Aashita, Yadav V, Sharma R, et al.. Mucosal melanoma: a series of seven cases and review of literature. J Cancer Res Ther. 2024, 20:1775-80. 10.4103\/JCRT.JCRT_1682_23","journal-title":"J Cancer Res Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK-25-473858","article-title":"Therapeutic approaches to mucosal melanoma","volume":"45","author":"Lian B","year":"2025","unstructured":"Lian B, Guo J. Therapeutic approaches to mucosal melanoma. Am Soc Clin Oncol Educ Book. 2025, 45:e4733858. 10.1200\/EDBK-25-473858","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20775","article-title":"Postoperative radiotherapy for primary mucosal melanoma of the head and neck","volume":"103","author":"Temam S","year":"2005","unstructured":"Temam S, Mamelle G, Marandas P, et al.. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer. 2005, 103:313-9. 10.1002\/cncr.20775","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/785131","article-title":"Mucosal melanomas of the head and neck: the role of postoperative radiation therapy","volume":"2012","author":"Saigal K","year":"2012","unstructured":"Saigal K, Weed DT, Reis IM, Markoe AM, Wolfson AH, Nguyen-Sperry J. Mucosal melanomas of the head and neck: the role of postoperative radiation therapy. ISRN Oncol. 2012, 2012:785131. 10.5402\/2012\/785131","journal-title":"ISRN Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.9258","article-title":"Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis","volume":"35","author":"D'Angelo SP","year":"2017","unstructured":"D'Angelo SP, Larkin J, Sosman JA, et al.. Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis. J Clin Oncol. 2017, 35:226-35. 10.1200\/JCO.2016.67.9258","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0207-6","article-title":"Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006","volume":"119","author":"Hamid O","year":"2018","unstructured":"Hamid O, Robert C, Ribas A, et al.. Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006. Br J Cancer. 2018, 119:670-4. 10.1038\/s41416-018-0207-6","journal-title":"Br J Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/450488-primary-gingival-mucosal-melanoma-a-case-report-and-comparison-with-cutaneous-melanoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:23:23Z","timestamp":1784168603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/450488-primary-gingival-mucosal-melanoma-a-case-report-and-comparison-with-cutaneous-melanoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.112748","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,15]]}}}